Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say.
Dec 8, 2022
0
278
In type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of insulin. One of the earliest targets of this immune response is a specific ...
Jul 25, 2022
0
130
To an immunologist, autoimmune diseases like Type 1 diabetes are the polar opposite of cancer. In the former, the immune system goes into overdrive and attacks the body's own organs in a relentless manner, eventually causing ...
Nov 30, 2021
0
134
New findings from the international The Environmental Determinants of Diabetes in the Young (TEDDY) study add to a growing body of evidence indicating that type 1 diabetes is not a single disease. The presentation and, perhaps, ...
Oct 21, 2021
0
0
Scientists have completed the largest and most diverse genetic study of Type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
Jul 22, 2021
0
88
Researchers from the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Campus have found that immune responses to insulin could help identify individuals most at risk for developing ...
Feb 8, 2021
0
30
Researchers at the University of Utah School of Medicine have identified a new therapeutic target to treat patients with type 1 diabetes. The study, which will be published December 9 in the Journal of Experimental Medicine (JEM), ...
Dec 9, 2020
0
19
More than 34 million Americans are living with diabetes. And many of them are children and adolescents. Cases of Type 1 and Type 2 diabetes are on the rise among those 20 and under in the U.S., according to a study earlier ...
Nov 16, 2020
0
9
Tuulia Hyötyläinen and Matej Orešič, both researchers in biomedicine, have published two studies on the connection between highly fluorinated chemicals—per- and polyfluoroalkyl substances (PFASs) – and two diseases ...
Sep 3, 2020
0
17
Cases of Type 1 and Type 2 diabetes are on the rise among those 20 and under in the U.S., according to the Centers for Disease Control and Prevention. In this Mayo Clinic Minute, Dr. Ana Creo, a Mayo Clinic pediatric endocrinologist, ...
Mar 13, 2020
0
6
